OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

FRONTLINE PLC/  CY0200352116  /

Turquoise
2024-06-07  4:19:43 PM Chg. -3.60 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
282.60NOK -1.26% 35,595
Turnover: 10 mill.		 -Bid Size: - -Ask Size: - 64.04 bill.NOK - -
GlobeNewswire 06-06 Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European...
GlobeNewswire 06-04 HeartSciences Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire 06-04 Verizon Frontline supports wildfire response efforts in New Mexico
GlobeNewswire 06-04 Irdeto and Velociti Partner to Revolutionize Fleet Management by Building a Keyless Future
GlobeNewswire 06-03 Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasd...
GlobeNewswire 06-03 Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival ...
GlobeNewswire 06-03 Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
GlobeNewswire 06-03 NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
GlobeNewswire 05-31 Verizon Business brings the Verizon Business Innovation Sessions to New York City
GlobeNewswire 05-31 Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire 05-31 Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...
GlobeNewswire 05-30 FRO – Q1 2024 Presentation
GlobeNewswire 05-30 FRO – First Quarter 2024 Results
GlobeNewswire 05-28 Meritus CEO: We can’t afford not to invest in our dedicated workforce
GlobeNewswire 05-28 ZeroFox Announces Leadership Transition
GlobeNewswire 05-28 Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hosp...
GlobeNewswire 05-27 FRO – Invitation to Q1 2024 Results Conference Call and Webcast
GlobeNewswire 05-27 Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire 05-24 Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
GlobeNewswire 05-23 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire 05-23 Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire 05-21 Verizon Frontline showcases public safety solutions at Border Security Expo
GlobeNewswire 05-21 Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Ph...
GlobeNewswire 05-20 HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
GlobeNewswire 05-20 Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...